Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969382019> ?p ?o ?g. }
- W2969382019 abstract "Adolescents with perinatally acquired HIV (PHIV) are at risk of chronic disease due to long-standing immune suppression, HIV disease and antiretroviral therapy (ART) exposure. However, there are few data on multisystem disease in this population. We investigated the overlapping burden of neurocognitive, cardiovascular, respiratory and/or renal impairment among PHIV positive (PHIV+) adolescents.In this cross-sectional analysis, participants aged 9 to 14 years on ART for >6 months were recruited from seven sites across Cape Town from July 2013 through March 2015, together with age-matched HIV-negative (HIV-) adolescents. Impairment at enrolment was assessed across neurocognitive functioning (using the youth-International HIV Dementia Scale); cardiac function (echocardiogram abnormality); respiratory function (abnormal spirometry) and renal function (abnormal glomerular filtration rate).Overall, 384 PHIV+ and 95 HIV- adolescents were included (mean age, 11.9 years; 49% female). Median age of ART initiation was 4.2 years (IQR: 1.7 to 7.6) and median CD4 count was 709 (IQR: 556 to 944) with 302 (79%) of PHIV+ adolescents virologically suppressed. Abacavir and Zidovudine were the most commonly used nucleoside reverse transcriptase inhibitors (NRTIs) with 60% of adolescents on non-nucleoside reverse transcriptase inhibitors (NNRTI) and 38% on a protease inhibitor (PI). Among PHIV+ adolescents, 167 (43.5%) had single system impairment only, 110 (28.6%) had two systems involved, and 39 (10.2%) had three or four systems involved. PHIV+ participants had more 2-system and 3-system impairment than HIV-, 110 (28.6%) versus 17 (17.9%), p = 0.03 and 39 (10.2%) versus 3 (4.3%), p = 0.03. PHIV+ participants who had failed a year of school (73.8% vs. 46.4%, p = 0.00) and with a viral load >1000 copies/mL at enrolment (16.8% vs. 8.1%, p = 0.03) were more likely to have dual or multisystem impairment. Of those with cardiac impairment, 86.7% had an additional system impaired. Similarly, in those with neurocognitive impairment, almost 60% had additional systems impaired and of those with respiratory impairment, 74% had additional systems impaired.Despite relatively early ART initiation, there is a substantial burden of multisystem chronic impairment among PHIV+ adolescents. This phenomenon needs to be further explored as this population ages and begins to engage in adult lifestyle factors that may compound these impairments." @default.
- W2969382019 created "2019-08-29" @default.
- W2969382019 creator A5007027286 @default.
- W2969382019 creator A5011540954 @default.
- W2969382019 creator A5019353471 @default.
- W2969382019 creator A5042421942 @default.
- W2969382019 creator A5056446038 @default.
- W2969382019 creator A5056730886 @default.
- W2969382019 creator A5062090052 @default.
- W2969382019 creator A5062574168 @default.
- W2969382019 creator A5073216705 @default.
- W2969382019 creator A5083472606 @default.
- W2969382019 creator A5084732324 @default.
- W2969382019 creator A5090889269 @default.
- W2969382019 date "2019-08-01" @default.
- W2969382019 modified "2023-10-14" @default.
- W2969382019 title "Multisystem impairment in South African adolescents with Perinatally acquired <scp>HIV</scp> on antiretroviral therapy ( <scp>ART</scp> )" @default.
- W2969382019 cites W1567692140 @default.
- W2969382019 cites W1822037535 @default.
- W2969382019 cites W1964767844 @default.
- W2969382019 cites W1990717001 @default.
- W2969382019 cites W2012392023 @default.
- W2969382019 cites W2043643815 @default.
- W2969382019 cites W2086670360 @default.
- W2969382019 cites W2099449365 @default.
- W2969382019 cites W2119483101 @default.
- W2969382019 cites W2121401294 @default.
- W2969382019 cites W2122855609 @default.
- W2969382019 cites W2124879124 @default.
- W2969382019 cites W2125078269 @default.
- W2969382019 cites W2125577155 @default.
- W2969382019 cites W2127311714 @default.
- W2969382019 cites W2136356633 @default.
- W2969382019 cites W2142010704 @default.
- W2969382019 cites W2146578470 @default.
- W2969382019 cites W2146965595 @default.
- W2969382019 cites W2148924243 @default.
- W2969382019 cites W2152633758 @default.
- W2969382019 cites W2160234571 @default.
- W2969382019 cites W2163264029 @default.
- W2969382019 cites W2163842121 @default.
- W2969382019 cites W2168876945 @default.
- W2969382019 cites W2174134445 @default.
- W2969382019 cites W2262354148 @default.
- W2969382019 cites W2291139554 @default.
- W2969382019 cites W2293035635 @default.
- W2969382019 cites W2400179378 @default.
- W2969382019 cites W2509123133 @default.
- W2969382019 cites W2523347217 @default.
- W2969382019 cites W2593791583 @default.
- W2969382019 cites W2607031541 @default.
- W2969382019 cites W2753563336 @default.
- W2969382019 cites W2792621062 @default.
- W2969382019 cites W2793658602 @default.
- W2969382019 cites W2801969480 @default.
- W2969382019 cites W2883656860 @default.
- W2969382019 cites W2888569161 @default.
- W2969382019 cites W2891423083 @default.
- W2969382019 cites W2894654797 @default.
- W2969382019 cites W2895488597 @default.
- W2969382019 cites W2908798706 @default.
- W2969382019 cites W2969382019 @default.
- W2969382019 cites W4250875913 @default.
- W2969382019 doi "https://doi.org/10.1002/jia2.25386" @default.
- W2969382019 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6706702" @default.
- W2969382019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31441211" @default.
- W2969382019 hasPublicationYear "2019" @default.
- W2969382019 type Work @default.
- W2969382019 sameAs 2969382019 @default.
- W2969382019 citedByCount "9" @default.
- W2969382019 countsByYear W29693820192020 @default.
- W2969382019 countsByYear W29693820192021 @default.
- W2969382019 countsByYear W29693820192022 @default.
- W2969382019 countsByYear W29693820192023 @default.
- W2969382019 crossrefType "journal-article" @default.
- W2969382019 hasAuthorship W2969382019A5007027286 @default.
- W2969382019 hasAuthorship W2969382019A5011540954 @default.
- W2969382019 hasAuthorship W2969382019A5019353471 @default.
- W2969382019 hasAuthorship W2969382019A5042421942 @default.
- W2969382019 hasAuthorship W2969382019A5056446038 @default.
- W2969382019 hasAuthorship W2969382019A5056730886 @default.
- W2969382019 hasAuthorship W2969382019A5062090052 @default.
- W2969382019 hasAuthorship W2969382019A5062574168 @default.
- W2969382019 hasAuthorship W2969382019A5073216705 @default.
- W2969382019 hasAuthorship W2969382019A5083472606 @default.
- W2969382019 hasAuthorship W2969382019A5084732324 @default.
- W2969382019 hasAuthorship W2969382019A5090889269 @default.
- W2969382019 hasBestOaLocation W29693820191 @default.
- W2969382019 hasConcept C118552586 @default.
- W2969382019 hasConcept C126322002 @default.
- W2969382019 hasConcept C142462285 @default.
- W2969382019 hasConcept C159641895 @default.
- W2969382019 hasConcept C169900460 @default.
- W2969382019 hasConcept C172467417 @default.
- W2969382019 hasConcept C203014093 @default.
- W2969382019 hasConcept C2780216070 @default.
- W2969382019 hasConcept C2780727368 @default.
- W2969382019 hasConcept C2781432083 @default.
- W2969382019 hasConcept C2908647359 @default.
- W2969382019 hasConcept C2993143319 @default.